20-HETE in neovascularization
Authors:
- Rachel AckermanRARachel Ackerman
- Austin M. GuoAGAustin M. Guo
- 1 August 2012
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 98 (3-4) , 63-68
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- The Cytochrome P450 4A/F-20-Hydroxyeicosatetraenoic Acid System: A Regulator of Endothelial Precursor Cells Derived from Human Umbilical Cord BloodThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamicsExperimental Eye Research, 2011
- Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancerCancer Chemotherapy and Pharmacology, 2010
- RhoA/ROCK signaling is essential for multiple aspects of VEGF‐mediated angiogenesisThe FASEB Journal, 2010
- 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Mediates Endothelial Dysfunction via IκB Kinase-Dependent Endothelial Nitric-Oxide Synthase UncouplingThe Journal of Pharmacology and Experimental Therapeutics, 2010
- The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor NeovascularizationThe Scientific World Journal, 2010
- Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injuryKidney International, 2009
- The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesisTrends in Immunology, 2007
- Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formationBiochemical Journal, 2007
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004